SurModics SRDX 深 滬
已收盤 11-14 16:00:00 美东时间
41.61
+0.200
+0.48%
華盛通- 最 高41.75
- 今 開41.36
- 成交量 45.08万股
- 最 低 41.36
- 昨 收 41.41
- 總市值 5.95亿
- 52周最高 41.75
- 市盈率 靜 --
- 換手率 3.15%
- 52周最低 25.87
- 委 比 76.57%
- 總股本 1429.76万
- 歷史最高 82.35
- 量 比 0.51
- 振 幅 0.94%
- 歷史最低 8.73
- 每 手 1
- 風險率 4.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Barrington Research Downgrades Surmodics to Underperform
Barrington Research analyst Michael Petusky downgrades Surmodics (NASDAQ:SRDX) from Market Perform to Underperform.
今天 02:07
美股牛股 | ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%
ENGN隔夜大涨近47%！膀胱癌基因疗法试验数据表现积极；二手奢侈品在线交易平台REAL涨超38%，Q3业绩超预期及上调财年销售指引>>
11-12 18:55
Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge
A U.S. court denied the FTC's bid to block GTCR's $627 million acquisition of Surmodics, clearing the way for the merger to proceed.
11-12 01:00
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index gaining more than 100 points o...
11-11 23:08
Surmodics surges after court denies injunction to block sale to GTCR
Surmodics (SRDX) soared 49% in premarket trading after a federal court rejected a request by the Federal Trade Commission to block its planned sale to GTCR. Judge Jeffrey Cummings denied the FTC's mo...
11-11 21:27
U.S. Court Denies U.S. Federal Trade Commission's Bid To Block GTCR's Acquisition Of Surmodics
- Reuters Citing Court Hearing
11-11 05:59
Surmodics To Present PROWL Registry Sex-Specific Data From Analysis Of 160 Participants At TCT Symposium On Oct. 28
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific
10-28 04:11
GTCR purchase of Surmodics would hurt medical device market, FTC says
Private equity firm GTCR's planned purchase of medical device coatings firm Surmodics (NASDAQ:SRDX) would harm competition in the market, the Federal Trade Commission said on the first day of a trial ...
08-22 02:43
Barrington Research Reiterates Market Perform on Surmodicsto Market Perform
Barrington Research analyst Michael Petusky reiterates Surmodics (NASDAQ:SRDX) from Market Perform to Market Perform.
08-11 19:52
Surmodics Raises FY2025 Adj EPS Guidance from $(0.62)-$(0.42) to $(0.35)-$(0.20) vs $(0.55) Est; Raises FY2025 Sales Guidance from $114.000M-$117.000M to $116.500M-$118.500M vs $115.686M Est
Fiscal Year 2025 Financial GuidanceSurmodics is increasing its fiscal 2025 total revenue to a range of $116.5 million to $118.5 million, representing a decrease of 8% to 6% compared to fiscal 2024. Excluding SurVeil DCB
08-08 19:05
